C-24WPGameto
cell engineering, iPSC-derived technology, ovarian support cells
replacementreplacingcell therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-24WP
C-24WPC-24WPcell engineering, iPSC-derived technology, ovarian support cells
0-100 chain-logic scale · 15 dimensions · scored on public evidence
No company beliefs, mission, or theory statements are visible in this snapshot; the archived page appears to be only a placeholder reading "coming soon."
SourceGameto states that female reproductive health has been neglected, that diseases of the female reproductive system have too few effective treatment options, and that existing options often cause complications and provide limited benefit. The company says it believes cell engineering and cellular engineering can produce better therapeutics, improve lives, and potentially cure diseases affecting the female reproductive system.
SourceGameto states that female reproductive longevity should be redefined by addressing what it calls accelerated or "fast ovarian aging." The company says the ovaries age faster than the rest of the human body, and that this process leads to infertility, menopause, and more years spent in poor health. It also presents fast ovarian aging as a root cause of broader inequality problems in society.
Source